GIP+GLP-1 microneedle patch is a groundbreaking, non-invasive alternative to traditional GLP-1 injections for weight loss , blood sugar control , and type 2 diabetes management
In January 2026, the FDA removed the suicide warning for GLP-1 receptor agonists
PMID: 40685889
Were honored to welcome patients who travel across for our expert, results-driven aesthetic care
This is often related to metabolic adaptation, inadequate protein intake, or the need for a dose adjustment
When deciding between oral and transdermal estrogen, here at Alloy, we focus on what works best for you, your health profile, and your lifestyle